rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2002-7-24
|
pubmed:abstractText |
To evaluate the long-term oncologic efficacy and morbidity of carboplatin monotherapy, which was introduced at our department 11 years ago for the treatment of Stage I seminoma. Radiotherapy is the standard treatment of patients with clinical Stage I seminoma. Carboplatin has been advocated as a treatment alternative to avoid the late side effects of radiotherapy and the high recurrence rate of surveillance strategies.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1527-9995
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
60
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
324-8
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:12137835-Adult,
pubmed-meshheading:12137835-Antineoplastic Agents,
pubmed-meshheading:12137835-Carboplatin,
pubmed-meshheading:12137835-Chemotherapy, Adjuvant,
pubmed-meshheading:12137835-Follow-Up Studies,
pubmed-meshheading:12137835-Humans,
pubmed-meshheading:12137835-Male,
pubmed-meshheading:12137835-Middle Aged,
pubmed-meshheading:12137835-Orchiectomy,
pubmed-meshheading:12137835-Retrospective Studies,
pubmed-meshheading:12137835-Seminoma,
pubmed-meshheading:12137835-Testicular Neoplasms
|
pubmed:year |
2002
|
pubmed:articleTitle |
Long-term experience with carboplatin monotherapy for clinical stage I seminoma: a retrospective single-center study.
|
pubmed:affiliation |
Department of Urology, University of Innsbruck, Innsbruck, Austria.
|
pubmed:publicationType |
Journal Article
|